Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
The Journal of Biological Chemistry|May 24, 1996
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identificationM J Bossard, T A Tomaszek, S K Thompson, et al.Biochemistry|January 8, 2000
Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteasesM J Bossard, T A Tomaszek, M A Levy, et al.Molecular and Biochemical Parasitology|July 1, 1994
Analysis of expressed sequence tags from Plasmodium falciparumD Chakrabarti, G R Reddy, J B Dame, et al.Gene|December 1, 1991
The CYP2 gene of Saccharomyces cerevisiae encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase with an N-terminal signal sequenceP L Koser, D J Bergsma, R Cafferkey, et al.The New England Journal of Medicine|July 5, 1990
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based testsB L Triggs-Raine, A S Feigenbaum, M Natowicz, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivoB J Votta, M A Levy, A Badger, et al.Hamostaseologie|September 11, 2012
BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisationP L Turecek, M J Bossard, M Graninger, et al.Molecular and Biochemical Parasitology|July 1, 1996
Current status of the Plasmodium falciparum genome projectJ B Dame, D E Arnot, P F Bourke, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.Pageof 12